Outpatient drug expenditures and prescription policies for diseases with high cost to the National Health Insurance system in Taiwan

Journal of the Formosan Medical Association

Volumn 103, Issue 4, 2004, Pages 280-285

  Lang, Hui Chu ^a   Lai, Mei Shu ^b   Chen, Gau Tzu ^c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c KOO FOUNDATION SUN YAT SEN CANCER CENTER   (Taiwan)

Author keywords

Economics, pharmaceutical; Health expenditure; Health insurance; Respitatory tract infections

Indexed keywords

RESPIRATORY TRACT AGENT;

ARTICLE; COMMON COLD; DATA ANALYSIS; DRUG COST; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HUMAN; LARYNGITIS; MEDICAL RECORD; NATIONAL HEALTH INSURANCE; OUTPATIENT CARE; OUTPATIENT DEPARTMENT; PHARYNGITIS; PRESCRIPTION; PROSPECTIVE PAYMENT; REIMBURSEMENT; RESOURCE ALLOCATION; RESPIRATORY TRACT DISEASE; RHINOPHARYNGITIS; SELF CARE; SINUSITIS; TAIWAN; TONSILLITIS; TRACHEITIS; UPPER RESPIRATORY TRACT INFECTION; ADOLESCENT; ADULT; AGED; AMBULATORY CARE; DATA BASE; ECONOMICS; MIDDLE AGED; PUBLIC HEALTH; STATISTICS;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE; DATABASES; DRUG COSTS; HEALTH EXPENDITURES; HEALTH POLICY; HUMANS; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; RESPIRATORY TRACT DISEASES; TAIWAN;

EID: 3342965192     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Department of Health, the Executive Yuan, Republic of China: National Health Insurance Annual Statistical Report, 2001. Taipei: Bureau of National Health Insurance; June 2002:314-5.
2. Organization for Economic Co-operation and Development: OECD Health Data 2002: A Comparative Analysis of 30 Countries. 4th edition, 2002. Washington, DC: OECD, 2002.
3. West JV: Acute upper airway infections. Br Med Bull 2002;61:215-30.
4. English JA, Bauman KA: Evidence-based management of upper respiratoty infection in a family practice teaching clinic. Fam Med 1997;29:38-41.
5. Tylenol cold tablets (acetaminophen, chlorpheniramine, pseudoephedrine): Physicians' Desk Reference. 54th ed. Montvale, NJ: Medical Economics Company; 2000: 1676-7.
6. Gaedigk A: Interethnic differences of drug-metabolizing enzymes. Int J Clin Pharmacol Ther 2000;38:61-8.
7. Snow V, Mottur-Pilson C, Gonzales R: Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults. Ann Intern Med 2001;143:487-9.
8. Fahey T, Stocks N, Thomas T: Systematic review of the treatment upper respiratory tract infection. Arch Dis Child 1998;79:225-30.
9. Huang SM: URI outpatient utilization. Technical Report of Second Generation National Health Insurance Conference, 2002.
10. Chen GT, Tam YH: The Benefit Plan for NHI Drugs. Report of Second Generation National Health Insurance. Taipei: Executive Yuan; 2003: 197-202.
11. Covington TR: Ed. Handbook of nonprescription drugs. 11th ed. Washington, DC: American Pharmaceutical Association. The National Professional Society of Pharmacists, 1996.
12. Humphrey-Durham Drug Prescription Act, Pub L No. 82-215. 65 Stat 648-649 (October 26, 1951).
13. Gossel EA: Implications of reclassification of drugs from prescription-only to over-the-counter status. Clin Ther 1991;13:200-15.
14. Stuart B, Zacker C: Who bears the burden of Medicaid drug copayment policies? Health Aff 1999;18:201-12.
15. Soumerai SB, Ross-Degnan D, Avorn J, et al: Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes. N Engl J Med 1991;325:1072-7.
16. Johnson RE, Goodman MJ, Hornbrook MC, et al: The effect of increased prescription drug cost-sharing on medical care utilization and expenses of elderly health maintenance organization members. Med Care 1997;35:1119-31.
17. Harris BL, Stegachis A, Ried LD: The effect of drug co-payments on utilization and cost of pharmaceutics in a health maintenance organization. Med Care 1990;28:907-1017.
18. Joyce GF, Escarce JJ, Solomon MD, et al: Employer drug benefit plans and spending on prescription drugs. JAMA 2002;288: 1733-9.
19. Tamblyn R, Laprise R, Hanley JA, et al: Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA 2001;285:421-9.
20. Brass EP: Changing the status of drugs from prescription to over-the-counter availability. N Engl J Med 2001;345:810-6.